LivaNova PLC (LIVN) Guidance & Earnings Results

On 2026-08-05 LivaNova PLC raised guidance: "FY2026 revenue growth raised to 8-9% from 7-8% on constant-currency basis; FY2026 adjusted diluted EPS raised to $4.30-$4.40 from $4.20-$4.30; FY2026 adjusted free cash flow lowered to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LIVNLivaNova PLCFollow LIVN — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 4.5B
P/E TTM: 23.9
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
5 Aug 26	Raised	FY2026 revenue growth raised to 8-9% from 7-8% on constant-currency basis; FY2026 adjusted diluted EPS raised to $4.30-$4.40 from $4.20-$4.30; FY2026 adjusted free cash flow lowered to $140-160M · full year
6 May 26	Raised	Revenue growth guidance raised by 100 bps to 7-8% constant-currency; adjusted diluted EPS raised by $0.05 to $4.20-$4.30 · full year
25 Feb 26	Raised	FY2026 constant-currency revenue growth 6-7%; adjusted EPS $4.15-$4.25 · full year
5 Nov 25	Raised	Revenue growth raised to 8.5%-9.5% constant-currency (from 8.0%-9.0%); adjusted EPS to $3.80-$3.90 (from $3.70-$3.80); adjusted FCF to $160M-$180M (from $140M-$160M) · full year
6 Aug 25	Raised	FY2025 revenue growth raised to 8.0-9.0% constant-currency (from prior 6.0-7.0% implied) and 9.0-10.0% organic; FY2025 adjusted EPS raised to $3.70-3.80 (from $3.60-3.70 implied); FY2025 adjusted FCF raised to $140-160M (from $135-155M implied) · full year

LivaNova PLC — questions

What guidance did LivaNova PLC give?: On 2026-08-05: "FY2026 revenue growth raised to 8-9% from 7-8% on constant-currency basis; FY2026 adjusted diluted EPS raised to $4.30-$4.40 from $4.20-$4.30; FY2026 adjusted free cash flow lowered to $140-160M"
When does LivaNova PLC report earnings?: LivaNova PLC's next earnings report is expected on 2026-11-04.

Every figure on this page comes from LivaNova PLC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.